Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 103
Filter
2.
J Biomed Mater Res B Appl Biomater ; 71(1): 130-43, 2004 Oct 15.
Article in English | MEDLINE | ID: mdl-15368237

ABSTRACT

In this study, the proliferation and differentiation of rat calvarial osteoblasts cultured on either (1) calcium-phosphate bone cement Biocement D, (2) Biocement D with 2.5% (w/w) mineralized collagen type I, or (3) Biocement D with 2.5% (w/w) mineralized collagen type I and 3% (w/w) citric acid were investigated. Incubation of the composites in cell-culture medium resulted in a fast decrease of pH and calcium concentration as well as in an increase of phosphate concentration. Although these effects occurred with all investigated materials, the lowest extent could be observed for the citric-acid-containing composites. As shown by scanning-electron microscopy, osteoblasts adhered to the composite surfaces. Proliferation and differentiation of the cells grown on the composites were found to be reduced compared to cells grown on tissue-culture polystyrene. Cells cultured in the vicinity of the composites but without direct contact also exhibited a reduced rate of proliferation, reduced alkaline phosphatase activity, and reduced mineralization. Simulating the changes in calcium and phosphate concentration occasioned by the composites through exposing cells to EGTA and phosphate gives rise to the same effects of reducing proliferation, ALP activity, and mineralization. No indication for apoptosis in cells exposed to low calcium and high phosphate concentrations was found. The number of necrotic cells, however, increased after incubation with EGTA and phosphate. For assessment of cell-composite interactions and the success of the composites in vivo, as well as for more effective material development, it seems to be important to know how changes in microenvironmental pH and ion composition of the material affect cellular proliferation and differentiation.


Subject(s)
Bone Cements/pharmacology , Citric Acid/pharmacology , Collagen Type I/pharmacology , Osteoblasts/chemistry , Animals , Calcium Phosphates , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Survival/drug effects , Cells, Cultured , Materials Testing , Microscopy, Electron, Scanning , Organic Chemicals , Osteoblasts/drug effects , Osteoblasts/ultrastructure , Rats
3.
J Mater Sci Mater Med ; 15(4): 451-5, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15332616

ABSTRACT

Temporary bone replacement materials on the basis of calcium phosphates and hydroxyapatite (HAP) are used in surgery for filling bone defects. Components which are able to control the nucleation and crystal growth of HAP through their functional groups and which can additionally activate bone cells may be helpful in the development of materials with enhanced remodelling in vivo. In this study, the influence of O-phospho-L-serine (PS) on the materials properties of calcium phosphate bone cement composites was investigated. For up to an addition of 25 mg/g PS a strong increase in the stability of the cements under load was determined. The material was studied by scanning electron microscopy and transmission electron microscopy. A more dense microstructure and a plate-like morphology of the HAP-crystals were detected in the modified composites compared with the non-modified samples. By X-ray powder diffraction an inhibition of the dissolution of alpha-tricalcium phosphate (alpha-TCP) and dicalciumphosphate anhydrous (DCPA) particles was found. alpha-TCP and DCPA are the main constituents of the cement precursor. The results of cell culture studies using rat calvaria osteoblasts demonstrate a good viability of the cells on the PS-modified material. Furthermore, the proliferation and differentiation were found to be enhanced on the PS-modified material.


Subject(s)
Bone Cements/chemistry , Calcium Phosphates/chemistry , Collagen Type I/chemistry , Osteoblasts/cytology , Osteoblasts/physiology , Phosphoserine/chemistry , Tissue Engineering/methods , Animals , Animals, Newborn , Biocompatible Materials/chemical synthesis , Cell Differentiation , Cell Division , Cell Survival , Compressive Strength , Materials Testing , Molecular Conformation , Rats , Rats, Inbred WKY , Surface Properties , Tensile Strength
4.
Biomaterials ; 24(15): 2631-41, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12726717

ABSTRACT

Titanium and titanium alloys are often used for orthopedic and dental implants. Osseointegration of Ti6Al4V may be improved not only by precoating of the surface with extracellular matrix proteins like collagen type I but also by additional immobilization of growth factors. In the present study, transforming growth factor beta1 (TGF-beta1) which is known as an inducer of collagen synthesis was immobilized adsorptively on uncoated and collagen type I coated Ti6Al4V surfaces. TGF-beta1 was found immobilized slightly faster to collagen type I coated than to uncoated Ti6Al4V and released slower from the collagen coated material. Immobilized TGF-beta1 is biologically active for at least 3 weeks storage at 4 degrees C. Sterilization by ethylene oxide inactivates immobilized TGF-beta1. In osteoblasts cultured on implants with adsorptively immobilized TGF-beta1, mRNA level and specific catalytic activity of alkaline phosphatase as well as accumulation of calcium and phosphate were found reduced, whereas procollagen alpha1(I) mRNA level and the rate of collagen synthesis were increased.


Subject(s)
Collagen Type I/metabolism , Osteoblasts/metabolism , Titanium , Transforming Growth Factor beta/metabolism , Adsorption , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Alloys , Animals , Calcium/metabolism , Cells, Cultured , Coated Materials, Biocompatible , Collagen Type I/genetics , Materials Testing , Osteoblasts/cytology , Phosphates/metabolism , Procollagen/genetics , Procollagen/metabolism , Prostheses and Implants , Rats , Rats, Wistar , Transforming Growth Factor beta1
5.
J Biomed Mater Res ; 59(3): 516-27, 2002 Mar 05.
Article in English | MEDLINE | ID: mdl-11774310

ABSTRACT

Several attempts have been made to improve osseointegration of titanium alloy as an implant material by modification of its surface. In the present study, proliferation, differentiation, and mineralization of osteoblasts on type I collagen-coated Ti6Al4V were investigated. The activity of alkaline phosphatase and the accumulation of calcium by osteoblasts grown on titanium alloy were significantly higher compared to cells grown on polystyrene. Precoating of the implant surface with type I collagen did not extensively affect proliferation, the activity of alkaline phosphatase, collagen synthesis, calcium accumulation, or the mRNA levels for collagen I alpha1, osteopontin, osteocalcin, MMP-2, and TIMP-2. Maximum collagen synthesis by osteoblasts was observed at day 4 of culture independent of the type of implant material. The specific activity of alkaline phosphatase reached its maximum at day 18 of culture. Accumulation of calcium and elevated mRNA levels for osteocalcin were found at day 22. These results indicate that collagen-coating alone is not sufficient to accelerate differentiation of rat calvarial osteoblasts on Ti6Al4V.


Subject(s)
Coated Materials, Biocompatible/pharmacology , Collagen Type I/pharmacology , Osteoblasts/cytology , Titanium , Alloys , Animals , Calcification, Physiologic/drug effects , Cell Adhesion/drug effects , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Division/drug effects , Cells, Cultured , Osteoblasts/drug effects , Rats , Skull/cytology
6.
Eur Respir J ; 18(2): 347-56, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11529295

ABSTRACT

Several lines of evidence support the hypothesis of the involvement of altered proteoglycan deposition in the development of lung diseases. UDP-D-xylose: core protein beta-D-xylosyltransferase (UDP-xylosyltransferase; EC 2.4.2.26) is a key enzyme for the glycosylation of proteoglycan core proteins. This study examined the catalytic activity of UDP-xylosyltransferase in lung tissue and in isolated fibroblasts, as well as the deposition of the proteoglycans versican, biglycan and decorin in rat lung tissue during bleomycin-induced lung injury. Rats were given, endotracheally, a single dose of bleomycin. Deposition of proteoglycans in lung tissue was assessed by immunohistochemistry and the catalytic activity of xylosyltransferase was determined with an acceptor peptide of the sequence Q-E-E-E-G-S-G-G-G-Q-G-G as a substrate. The results show coincidence of increasing xylosyltransferase activities in lung tissue with accumulation of versican at alveolar entrance rings and in fibrotic regions in close proximity to alpha-smooth muscle actin-positive cells. In contrast, no changes in biglycan and decorin deposition in fibrotic lungs were observed, except for decorin in alveolar type II pneumocytes and alveolar macrophages. Bleomycin treatment of isolated rat lung fibroblasts resulted in a concentration-dependent increase of xylosyltransferase activity up to 2 mU bleomycin x mL(-1). The data suggest a participation of myofibroblasts with increased xylosyltransferase activities in accumulation of versican in fibrotic foci of injured lung tissue at the early stages of development of lung fibrosis.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Bleomycin/adverse effects , Lung Diseases/chemically induced , Lung Diseases/metabolism , Pentosyltransferases/metabolism , Proteoglycans/metabolism , Animals , Biopsy , Female , Fibroblasts/drug effects , Fibroblasts/metabolism , Glycosylation/drug effects , Immunoenzyme Techniques , Lung Diseases/enzymology , Lung Diseases/pathology , Rats , Rats, Wistar , UDP Xylose-Protein Xylosyltransferase
7.
Glycobiology ; 10(8): 803-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10929006

ABSTRACT

UDP-xylosyltransferase (UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase EC 2.4.2.26) initiates the formation of chondroitin sulfate in the course of proteoglycan biosynthesis. The enzyme catalyzes the transfer of D-xylose from UDP-D-xylose to specific serine residues in the core protein. A procedure for purification of xylosyltransferase from rat ear cartilage was developed which includes ammonium sulfate fractionation, chromatography on heparin-agarose, on Sephacryl S300 and finally a substrate affinity chromatography applying the dodeca peptide Q-E-E-E-G-S-G-G-G-Q-G-G. The specific activity of the purified enzyme was about 420 mU per mg protein. The purification factor was about 26.000 with 27% yield. In SDS-polyacrylamide gel electrophoresis, the highly purified enzyme is homogeneous and yields only a single distinct band of 78 kDa. An apparent molecular mass of 71 kDa was determined for the native enzyme. These data suggest a monomeric structure for the enzyme. Xylosyltransferase activity was found to depend essentially on the presence of divalent metal ions. The K(m) value for UDP-D-xylose was determined to 6.5 micromol/l and for the dodeca peptide Q-E-E-E-G-S-G-G-G-Q-G-G as xylose acceptor to 8 micromol/l.


Subject(s)
Cartilage/enzymology , Pentosyltransferases/isolation & purification , Pentosyltransferases/metabolism , Amino Acid Sequence , Animals , Chromatography, Affinity , Chromatography, Gel , Ear , Electrophoresis, Polyacrylamide Gel , Pentosyltransferases/chemistry , Rats , UDP Xylose-Protein Xylosyltransferase
8.
J Clin Psychiatry ; 60(8): 545-9, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10485637

ABSTRACT

BACKGROUND: This open study replicates and extends previous pilot work with BT STEPS, a self-therapy system to assess and treat obsessive-compulsive disorder (OCD) through exposure and ritual prevention. METHOD: 21 OCD patients entered this open trial, using a self-guiding manual and any Touch-Tone telephone to access computer-driven interviews via an Interactive Voice Response system. The patients also used the system to rate progress on rating scales. RESULTS: The results support those of the previous open study. Of the 21 patients, 16 (76%) completed self-assessment over a mean of 21 days. Of these, 10 patients (48%) went on to do 2 or more exposure and ritual prevention sessions over a mean of 64 days; they improved significantly on OCD symptoms, as much as is usual with serotonin reuptake inhibitor medication, and in mood and work/social adjustment. Improvement was predicted by baseline motivation and by rapid completion of self-assessment with BT STEPS, even though self-assessment alone was not therapeutic. CONCLUSION: The significant improvement in the intent-to-treat analysis was due to the subgroup of patients (48% of those who began BT STEPS) who went beyond self-assessment to do exposure and ritual prevention self-therapy at home guided by BT STEPS. A controlled trial is now needed.


Subject(s)
Behavior Therapy/methods , Manuals as Topic , Obsessive-Compulsive Disorder/therapy , Self Care , Adult , Attitude to Health , Aversive Therapy/methods , Female , Health Status , Humans , Male , Middle Aged , Motivation , Obsessive-Compulsive Disorder/diagnosis , Obsessive-Compulsive Disorder/psychology , Psychiatric Status Rating Scales/statistics & numerical data , Remote Consultation , Therapy, Computer-Assisted , Treatment Outcome
9.
Histochem Cell Biol ; 112(1): 41-9, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10461811

ABSTRACT

This study was performed to determine if rat articular chondrocytes express caveolin, the structural protein of caveolae, and to determine differences in the distribution of the caveolin subtypes 1, 2 and 3 in knee joints of newborn and adult rats. All three subtypes of caveolin were detected in adult cartilage by immunocytochemical staining. In newborn rats, only caveolin-1 was found in the hyaline cartilage. Caveolin-1, -2 and -3 messenger RNA and protein were also detected in chondrocyte cell cultures. Ultrastructural investigations of cell culture and cartilage tissue revealed the presence of caveolae at the plasma membrane of chondrocytes. These findings represent the first report on the different expression of caveolin isoforms, in particular the expression of the muscle cell-specific caveolin-3 in chondrocytes. There is evidence that caveolin-2 and -3 are upregulated during growth and development of articular cartilage, suggesting a role for caveolins in chondrocyte differentiation.


Subject(s)
Cartilage, Articular/metabolism , Caveolins , Chondrocytes/metabolism , Membrane Proteins/biosynthesis , Tibia/metabolism , Alginates , Animals , Animals, Newborn , Caveolin 1 , Caveolin 2 , Caveolin 3 , Cells, Cultured , DNA Primers/chemistry , Female , Fluorescent Antibody Technique, Indirect , Glucuronic Acid , Hexuronic Acids , Immunoenzyme Techniques , Knee Joint , Male , Membrane Proteins/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Tibia/cytology
10.
Br J Psychiatry ; 172: 406-12, 1998 May.
Article in English | MEDLINE | ID: mdl-9747402

ABSTRACT

BACKGROUND: Two studies tested whether subjects with obsessive-compulsive disorder could successfully use BT STEPS, a computer-aided system, to perform self-assessment for self-treatment of obsessive-compulsive disorder by exposure and ritual prevention. METHOD: Subjects were given a self-guiding manual and could use a touch-tone telephone to access computer-controlled Interactive Voice Response interviews at their convenience from home. Using the BT STEPS system, patients rated themselves and worked out a plan for individually tailored self-exposure therapy. RESULTS: Outcomes were similar in the two studies. Of the 63 subjects who used BT STEPS, 84% completed the self-assessment module. Most calls were made outside usual office hours. As expected, subjects did not improve merely by completing self-assessment. However, completion of self-assessment predicted later improvement with self-exposure therapy. CONCLUSIONS: Most subjects successfully completed self-assessment using BT STEPS from their homes. DECLARATION OF INTEREST: BT STEPS is a trademark of Pfizer, Inc. I.M.M., L.B. and J.H.G. have a financial interest in BT STEPS.


Subject(s)
Behavior Therapy/methods , Home Care Services , Obsessive-Compulsive Disorder/diagnosis , Therapy, Computer-Assisted , Adult , Female , Humans , Male , Manuals as Topic , Obsessive-Compulsive Disorder/therapy , Self-Assessment , Telephone , Treatment Outcome
11.
Biochem Biophys Res Commun ; 249(2): 456-60, 1998 Aug 19.
Article in English | MEDLINE | ID: mdl-9712718

ABSTRACT

In fibroblasts transforming growth factor-beta1 (TGF-beta1) regulates cell proliferation and turnover of macromolecular components of the extracellular matrix. Here, intracellular signaling events in growth-inhibited embryonic rat lung fibroblasts (RFL-6) upon stimulation with TGF-beta1 were investigated. TGF-beta1 rapidly induced the activation of c-Raf-1, MEK-1, and MAPK p42 and p44. The activation of this pathway by TGF-beta1 did not depend on autocrine platelet-derived growth factor (PDGF) or basic fibroblast growth factor (bFGF). Inhibition of the binding of growth factors to their tyrosine kinase receptors did not affect MAPK activation by TGF-beta1. Ras activation by TGF-beta1 was significantly lower compared to the activation by PDGF or bFGF. The intracellular transduction of the TGF-beta1 signal was completely suppressed by depletion or inhibition of protein kinase C (PKC). It is shown that calcium-dependent isoforms of PKC are required for MAPK activation by TGF-beta1.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Lung/metabolism , Mitogen-Activated Protein Kinase Kinases , Protein Kinase C/metabolism , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins c-raf/metabolism , Transforming Growth Factor beta/pharmacology , Animals , Cell Line , Embryo, Mammalian , Enzyme Activation , Fibroblasts/metabolism , MAP Kinase Kinase 1 , Platelet-Derived Growth Factor/metabolism , Rats , Signal Transduction , ras Proteins/metabolism
12.
J Clin Psychiatry ; 59(7): 358-65, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9714264

ABSTRACT

OBJECTIVE: To evaluate the efficacy and acceptability of a self-help program for mild-to-moderate depression that combined treatment booklets and telephone calls to a computer-aided Interactive Voice Response (IVR) system. METHOD: In an open trial, 41 patients from Boston, Massachusetts; Madison, Wisconsin; and London, England, used COPE, a 12-week self-help system for depression. COPE consisted of an introductory videotape and 9 booklets accompanied by 11 telephone calls to an IVR system that made self-help recommendations to patients based on information they entered. RESULTS: All 41 patients successfully completed the self-assessment in the booklets and telephone calls; 28 (68%) also completed the 12-week self-help program. Hamilton Rating Scale for Depression (HAM-D) and Work and Social Adjustment scores improved significantly (41% and 42% mean reduction in the intent-to-treat sample, respectively, p < .001). Eighteen (64%) of the 28 completers were considered responders on the basis of > or = 50% reduction in their HAM-D scores. There was a higher percentage of completers in the pooled U.S. sites (82% vs. 43%), and U.S. completers improved more than those in the United Kingdom (73% vs. 43% were responders). Most (68%) of the calls were made outside usual office hours, Monday-Friday, 9:00 a.m. to 5:00 p.m. Expectation of effectiveness and time spent making COPE calls (more treatment modules) correlated positively with improvement over 12 weeks. Mean call length for completers was 14 minutes. CONCLUSION: A self-help system comprised of a computer-aided telephone system and a series of booklets was used successfully by people with mild-to-moderate depression. These preliminary results are encouraging for people who cannot otherwise access ongoing, in-person therapy.


Subject(s)
Depressive Disorder/therapy , Pamphlets , Psychotherapy/methods , Self Care/methods , Telephone , Therapy, Computer-Assisted , Adult , Aged , Boston , Depressive Disorder/diagnosis , England , Female , Humans , London , Male , Middle Aged , Psychiatric Status Rating Scales/statistics & numerical data , Remote Consultation , Severity of Illness Index , Treatment Outcome , United States , Videotape Recording
13.
MD Comput ; 15(3): 149-57, 1998.
Article in English | MEDLINE | ID: mdl-9617085

ABSTRACT

Bt steps is a patient-centered behavioral therapy program that uses a manual and a computer-driven interactive voice response system to assess and treat obsessive compulsive disorder. This nine-step program contains a self-assessment module and a self-treatment module that provides teaching on exposure and ritual prevention. The patient reads about the steps in a manual and then uses a touch-tone telephone to contact the program, in which a recorded voice conducts the interview. Of 40 patients in an open 12-week trial in the United States and London, 35 completed the self-assessment module, and 17 completed at least two sessions of exposure and ritual prevention. The system produced statistically significant improvements on measures of obsessive compulsive disorder.


Subject(s)
Behavior Therapy/methods , Obsessive-Compulsive Disorder/therapy , Self Care/methods , Therapy, Computer-Assisted , Adult , Female , Humans , Interviews as Topic , Male , Middle Aged , Patient Participation , Patient Satisfaction , Pilot Projects , Reproducibility of Results , Self-Assessment , Treatment Outcome , United Kingdom , United States
14.
Clin Chim Acta ; 271(1): 45-56, 1998 Mar 09.
Article in English | MEDLINE | ID: mdl-9564556

ABSTRACT

Changes in the activities of several proteinases and their inhibitors were investigated during the development of bleomycin-induced pulmonary fibrosis in rat. Studies on the proteinase-anti-proteinase-ratio may contribute to the understanding of the mechanism of the development of pulmonary fibrosis and may help to develop therapeutic strategies to prevent tissue damage by proteolytic attack. In the acute inflammatory period the activity of metalloelastase in lung tissue increased by about 10-fold. The time course of changes in the activity of 72 kD gelatinase indicates that this gelatinase accounts at least partially for the elastolytic activity. Elastase inhibitory activity in lung tissue showed maxima at days 1 and 5 and high levels in the fibrotic phase. The increase of the elastase inhibitory activity at the beginning of the fibrotic period corresponds with elevated activity of alpha 2-macroglobulin. Alveolar fluid and alveolar macrophages did not contain elastase activity but contained high elastase inhibitory activity. During the period of chronic inflammation, the activities of the cathepsins L, B, H and S in lung tissue and in isolated alveolar macrophages were found to be strongly increased.


Subject(s)
Bleomycin/toxicity , Endopeptidases/metabolism , Lung/pathology , Protease Inhibitors/metabolism , Pulmonary Fibrosis/chemically induced , Animals , Cathepsins/metabolism , Disease Models, Animal , Female , Inflammation/physiopathology , Lung/enzymology , Macrophages, Alveolar/chemistry , Pancreatic Elastase/antagonists & inhibitors , Pancreatic Elastase/metabolism , Rats , Rats, Wistar , alpha-Macroglobulins/metabolism
15.
Histochem Cell Biol ; 109(1): 41-8, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9452954

ABSTRACT

Caveolin is a major structural protein of caveolae, also known as plasmalemmal vesicles, which are particularly abundant in type I pneumocytes and capillary endothelial cells of lung parenchyma. Here we demonstrate that caveolin expression in the alveolar epithelium of rats and mini pigs is strikingly downregulated after irradiation-induced lung injury. Indirect immunoperoxidase staining with polyclonal anti-caveolin antibodies, confirmed by double fluorescence studies with type I cell-specific monoclonal anti-cytokeratin antibodies or lectins, revealed a dramatic loss of caveolin immunoreactivity in type I pneumocytes. In contrast, caveolin expression increased in endothelial cells. Immunoblotting of lung homogenates from normal and irradiated rats using specific anti-caveolin antibodies confirmed the presence of caveolin in normal tissue and its marked decrease of expression in fibrotic tissue. The loss of caveolin as an important structural protein of caveolae in alveolar epithelial cells may be an early indicator of serious type I cell injury during fibrogenesis. The increase of caveolin immunoreactivity in endothelia of blood vessels may indicate that different types of caveolae and/or different regulatory mechanisms of caveolin expression exist.


Subject(s)
Caveolins , Membrane Proteins/biosynthesis , Pulmonary Alveoli/metabolism , Pulmonary Fibrosis/metabolism , Animals , Blotting, Western , Caveolin 1 , Embryonic and Fetal Development/physiology , Epithelium/metabolism , Epithelium/pathology , Pulmonary Alveoli/radiation effects , Pulmonary Alveoli/ultrastructure , Pulmonary Fibrosis/pathology , Rats , Rats, Inbred F344 , Swine , Swine, Miniature
16.
Eur Respir J ; 12(6): 1397-403, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9877498

ABSTRACT

After lung injury, the epithelial cells lining the alveolar surface in rat lung show an altered distribution of several membrane proteins. Pulmonary fibrosis was induced by intratracheal administration of bleomycin into the lung of rats and the distribution of RTI40, a recently detected alveolar epithelial type I cell antigen, was examined, as well as the relationship between RTI40 and a type I cell-specific antigen recognized by the monoclonal antibody MEP-1 and the type I cell-binding lectin Bauhinia purpurea in serial sections and double stainings. Loss of RTI40 protein was observed in fibrotic lungs, particularly in areas with obliteration of alveoli. Pre-embedding immunoelectron microscopy confirmed this observation by detection of RTI40 protein in the alveolar lumen. Western blot analysis revealed elevated levels of RTI40 in the bronchoalveolar fluid of bleomycin-treated rats with a maximum at day 7 after treatment. Twenty-eight days after bleomycin application, the bronchoalveolar fluid contained three times the amount of RTI40 x mg protein(-1) of control lungs, as determined by semiquantitative dot blot. These results suggest RTI40 as a tool for the evaluation of alveolar epithelial type I cell behaviour during re-epithelialization processes.


Subject(s)
Membrane Proteins/immunology , Membrane Proteins/metabolism , Pulmonary Alveoli/metabolism , Pulmonary Fibrosis/metabolism , Animals , Antibodies, Monoclonal/immunology , Bleomycin , Blotting, Western , Epithelium/metabolism , Epitopes , Lectins/metabolism , Male , Membrane Glycoproteins , Microscopy, Immunoelectron , Pulmonary Alveoli/cytology , Pulmonary Alveoli/pathology , Pulmonary Fibrosis/chemically induced , Rats , Rats, Wistar
18.
FEBS Lett ; 403(1): 57-60, 1997 Feb 10.
Article in English | MEDLINE | ID: mdl-9038360

ABSTRACT

The transdifferentiation of hepatic stellate cells into myofibroblast-like cells and the proliferation of the transdifferentiated cells are controlled by TGF-beta1. Little is known about the intracellular signal transducers of TGF-beta1. In this paper we show that in cultured hepatic stellate cells TGF-beta1 induces activation of Ras, Raf-1, MEK and MAPK p42 and p44. The activation of MAPK depends on the activation of MEK. Our data exclude that the observed effects are mediated by a bFGF or PDGF autocrine loop.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Liver/cytology , Liver/metabolism , Mitogen-Activated Protein Kinase Kinases , Mitogen-Activated Protein Kinases , Transforming Growth Factor beta/pharmacology , ras Proteins/metabolism , Animals , Calcium-Calmodulin-Dependent Protein Kinases/drug effects , Enzyme Activation/drug effects , Fibroblast Growth Factor 2/metabolism , Fibroblast Growth Factor 2/pharmacology , Liver/drug effects , MAP Kinase Kinase 1 , Male , Mitogen-Activated Protein Kinase 1 , Mitogen-Activated Protein Kinase 3 , Platelet-Derived Growth Factor/metabolism , Platelet-Derived Growth Factor/pharmacology , Protein Serine-Threonine Kinases/drug effects , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/drug effects , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins/drug effects , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-raf , Rats , Rats, Wistar , ras Proteins/drug effects , ras Proteins/genetics
19.
Biochemistry ; 36(8): 1960-4, 1997 Feb 25.
Article in English | MEDLINE | ID: mdl-9047292

ABSTRACT

Hexokinase 2 from Saccharomyces cerevisiae is phosphorylated in vivo at serine-15 [Kriegel et al. (1994) Biochemistry 33, 148-152] and undergoes ATP-dependent autophosphorylation-inactivation in vitro when incubated in the presence of D-xylose [Fernandez et al. (1988) J. Gen. Microbiol. 134, 2493-2498]. This study identifies the site of inactivation by autophosphorylation as serine-158 by observation of a single tryptic peptide difference, peptide sequencing, and size determination by mass spectrometry. Mutation of serine-158 to alanine and cysteine, respectively, prevents autophosphorylation and causes a drastic decrease of the catalytic activity while mutational change to glutamate results in a complete loss of enzyme activity. The catalytically active mutant enzymes display an increased affinity for glucose and exhibit higher K(M) with respect to MgATP. Phosphoserine/phosphothreonine-specific protein phosphatase-2A completely reverses the autophosphorylative inactivation of the wild-type enzyme.


Subject(s)
Hexokinase/metabolism , Saccharomyces cerevisiae/enzymology , Alanine/genetics , Cysteine/genetics , Hexokinase/genetics , Phosphorylation , Point Mutation , Serine/genetics
20.
Virchows Arch ; 431(6): 441-8, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9428932

ABSTRACT

C-Jun and c-Fos transcription factors have been associated with enhanced cellular proliferation. We studied their cellular distribution in normal and fibrotic rat lung. Pulmonary fibrosis was induced by intratracheal administration of bleomycin. In normal rat lung, c-Jun and c-Fos are present in alveolar macrophages and type II pneumocytes, in the bronchiolar epithelium and in smooth muscle cells of bronchioli and blood vessels. Subcellular fractionation of proteins revealed a predominant presence of both c-Jun and c-Fos in the heavy membrane fraction containing mitochondria and secretory granules. This was confirmed by immunoelectron microscopy, which also revealed a different localization of c-Jun and c-Fos in different cell types. Whereas in type II pneumocytes and in macrophages cytoplasmic c-Jun and c-Fos is associated with mitochondria, in Clara cells of the bronchial epithelium only secretory granules contain c-Jun and c-Fos. In addition, c-Jun is strongly present in the nuclear fraction. In the fibrotic rat lung c-Jun and c-Fos are located in the same cell types as in control lungs. In addition, fibroblasts contain c-Jun and c-Fos in areas of proliferation whereas in areas of complete fibrosis there is only a very weak expression of c-Jun and c-Fos.


Subject(s)
Bleomycin/toxicity , Lung/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/metabolism , Pulmonary Fibrosis/metabolism , Animals , Blotting, Western , Female , Fluorescent Antibody Technique, Indirect , Immunohistochemistry , Lung/cytology , Macrophages, Alveolar/metabolism , Muscle, Smooth/metabolism , Pulmonary Fibrosis/chemically induced , Rats , Rats, Wistar , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...